In particular, Olainfarm is to provide Aminosalicylic Acid, used by the WHO to treat tuberculosis in developing countries in Asia and Africa.
Olainfarm has been producing the drug since 2001. Inter alia, it delivers Aminosalicylic Acid to clinics in the Baltics and to the international NGO, Médecins Sans Frontières, the company told the press.